Scientific Poster , Clinical Trial Manufacturing , Formulation Development , First-in-Human

How do I quickly develop first-in-human (FIH) dosage forms and avoid CMC delays whilst achieving proof-of-concept (POC)?

Overview

Download Quotient Sciences', 'How do I quickly develop first-in-human (FIH) dosage forms and avoid CMC delays whilst achieving proof-of-concept (POC)?'.

Our scientific poster includes the following:
 

  • Choosing the appropriate dosage form for first-in-human/Phase I trials. 
  • Pharmacy preparation or GMP manufacturing? 
  • Bridging to robust and scalable Phase II drug products. 
  • Flexible and adaptive clinical manufacturing strategies for patient trials. 
  • Integrating pharmaceutical sciences and clinical testing. 
Download